Fifth Third Bancorp
RLAY icon

Fifth Third Bancorp’s Relay Therapeutics RLAY Stock Holding History

Fifth Third Bancorp’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23K Buy
1,229
+565
+85% +$8.2K ﹤0.01% 3502
2026
Q1 		$6.61K Buy
+664
New +$5.94K ﹤0.01% 3799
2021
Q2 		– Sell
-100
Closed -$3K – 2511
2021
Q1 		$3K Buy
+100
New +$4.34K ﹤0.01% 2275

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Fifth Third Bancorp's RLAY Position: Q2 2026 in Review

Fifth Third Bancorp increased its Relay Therapeutics (RLAY) stake by 85% in Q2 2026, buying an estimated $8.2K and bringing the position to 1,229 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #3502.

Fifth Third Bancorp first reported a position in RLAY in Q1 2021 and has held it in 3 quarters since. 260 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Fifth Third Bancorp held 1,229 shares of Relay Therapeutics worth $23K as of Q2 2026.
  • Fifth Third Bancorp bought 565 Relay Therapeutics shares in Q2 2026, an estimated $8.2K.
  • Relay Therapeutics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3502 holding.
  • Fifth Third Bancorp first reported a position in Relay Therapeutics in Q1 2021 and has held it in 3 quarters since.
  • 260 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.